A method for constructing an immune repertoire-based spatial transcriptome sequencing library

By constructing spatial transcriptome sequencing libraries using Stereo-seq spatiotemporal chips and DNA circularization technology, the challenge of detecting clone typing of tumor-infiltrating immune cells has been solved. This enables highly sensitive and comprehensive spatiotemporal localization and gene sequencing of immune cells, supporting clinical tumor immunotherapy.

CN122168721APending Publication Date: 2026-06-09BGI RES SOUTHWEST
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411806436.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-12-09
Publication Date
2026-06-09

AI Technical Summary

Technical Problem

Currently, there is a lack of highly sensitive and comprehensive methods for detecting the clonal typing of immune cells infiltrating tumor tissue. In particular, when considering the small number of cells, low gene expression levels, and difficulties in spatial localization, existing technologies cannot effectively achieve the co-detection of immune repertoire and spatial transcriptome.

Method used

Stereo-seq spatiotemporal chip was used to capture mRNA in situ, and cDNA was synthesized by reverse transcription combined with direct DNA circularization. Specific binding primers were designed to enrich conserved C region genes of TCR/BCR, a spatial transcriptome sequencing library was constructed, and targeted PCR reaction was performed to improve capture specificity and sensitivity, thereby realizing spatiotemporal localization and gene sequencing of monoclonal immune cells.

Benefits of technology

It achieves highly sensitive and comprehensive tumor tissue infiltrating immune cell clone typing detection, can spatially locate the distribution and infiltration status of immune cells, determine clone type, and read TCR/BCR receptor gene sequences, and has important clinical application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122168721A_ABST
    Figure CN122168721A_ABST
Patent Text Reader

Abstract

The application relates to the field of biotechnology, in particular to a method for constructing a spatial transcriptome sequencing library based on an immune repertoire, which realizes targeted enrichment and high-throughput sequencing of TCR / BCR sequences through library molecule circularization and two rounds of enrichment, and is used for observing the space-time atlas of gene expression and immune response of immune cells.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This application relates to the field of biotechnology, specifically to a method for constructing a spatial transcriptome sequencing library based on an immune repertoire. Background Technology

[0002] At the forefront of immunological research, the surface receptors TCR and BCR of T cells and B cells play a crucial role. The genes for these receptors—IGH and IGL on B cells and TRA and TRB on T cells—are composed of a series of highly variable DNA regions, including variable (V), diversity (D), joining (J), and constant (C) regions. Through alternative splicing of these regions, a wide range of immune cell receptors can be generated, forming what we call an immune repertoire. This repertoire reflects the individual's immune diversity within a specific time and space. Research on immune repertoires is highly promising for the diagnosis, prognosis, and treatment of many diseases in clinical practice, making it a hot topic and highlight in cutting-edge medicine today, especially in tumor immunotherapy, where immune repertoires will provide more theoretical support.

[0003] In the determination of full-length sequences in immune repertoires, several emerging technologies and methods have shown great potential: RNA-based immunomic sequencing: Choosing RNA as a template avoids problems caused by intron separation in DNA templates, and obtains C-region information and full-length VDJ information through 5′RACE amplification. This method is particularly useful for differentiating immunoglobulin (Ig) subtypes because it provides additional C-region information; 5′RACE technology: 5′RACE (5′ end Race) technology reduces PCR bias and improves target efficiency by adding a known adapter sequence during cDNA synthesis and then using this adapter sequence for PCR amplification. This method does not rely on degenerate primers and can obtain full-length sequences more accurately. Single-cell sequencing technologies: such as the 10X Genomics platform, which uses microfluidics and oil droplet encapsulation technology to achieve high-throughput single-cell transcriptome and single-cell V(D)J sequencing, can match TCR / BCR duplexes and refine to the single-cell level, while obtaining expression profile information. sCircle single-cell full-length immune receptor library construction technology: The sCircle technology provided by Syngeon Biotech is based on the Singleon single-cell platform. It obtains cDNA through reverse transcription, and then performs circularization and linearization to enrich the full-length V(D)J sequence, thereby obtaining the full-length information of the immune receptor.

[0004] While single-cell full-length immune repertoire sequencing technology is relatively mature, high-throughput sequencing methods for immune repertoires based on tissue slices and spatial location information are currently unavailable. The development of co-detection technologies combining immune repertoires and spatial transcriptomics is also underway. Currently, there is no reliable technology for identifying the clonal typing of immune cells infiltrating tumor tissue. Through multiplex targeted PCR amplification, TCR / BCR molecules captured in spatiotemporal omics Stereo-seq chips can be efficiently enriched. Considering the limitations of solid tumor-infiltrating immune cells, such as small cell numbers, low gene expression levels, and difficulty in spatial localization, this invention optimizes the experimental protocol to achieve high-sensitivity and high-coverage detection of clonal typing of tumor-infiltrating immune cells, which will have significant practical implications for clinical tumor immunotherapy. Summary of the Invention

[0005] The present invention aims to at least partially solve one of the technical problems in the related art.

[0006] This invention utilizes Stereo-seq spatiotemporal chip-based in-situ capture of mRNA and reverse transcription-synthesized cDNA as templates. Through direct DNA circularization, specific binding primers are designed for genes in the conserved C region of the TCR / BCR (the conserved region of the TCR TRA gene is called TRAC, the conserved region of the TRB gene has two gene segments, TRBC1 and TRBC2, and the conserved region of the BCR IGH gene has multiple gene segments, including four homologous segments: IGHG1, IGHG2, IGHG3, and IGHG4. These four segments have largely identical DNA sequences, with some differences. The conserved region also includes gene segments such as IGHA and IGHE). This invention enriches the TCR / BCR immune library, fragments the enriched cDNA library for library construction and sequencing, and establishes a spatially targeted TOR / BCR PCR reaction system to improve capture specificity and sensitivity while reducing sequencing throughput, thus achieving a method for spatiotemporal localization and gene sequencing of monoclonal immune cells.

[0007] Therefore, a first aspect of the present invention proposes a method for constructing a spatial transcriptome sequencing library based on an immune repertoire, the method comprising the following steps:

[0008] (1) RNA from the immune repertoire was captured using a space chip to obtain spatially barcode-labeled cDNA;

[0009] The spatially barcoded cDNA includes, from 5' to 3', a first universal sequence, a spatial barcode sequence, a capture sequence, a target nucleic acid C region sequence, a target nucleic acid V region sequence, and a second universal sequence;

[0010] (2) Connect the 5' end of the first universal sequence to the 3' end of the second universal sequence to circularize the spatial barcode-tagged cDNA;

[0011] (3) The circularized spatially barcoded cDNA is enriched using the first primer pair to obtain the first enriched library molecule; the first enriched library molecule includes the following from 5' to 3': capture sequence, spatially barcoded sequence, first universal sequence, second universal sequence, target nucleic acid V region sequence and target nucleic acid C region sequence;

[0012] The first primer pair includes a forward primer and a reverse primer. The forward primer is partially or completely complementary to the capture sequence, the target nucleic acid C region sequence, or a sequence between the two. The reverse primer is partially or completely identical to the capture sequence, the target nucleic acid C region sequence, or a sequence between the two.

[0013] It is understood that the reverse primer can be partially or completely complementary to the extension product of the forward primer. Preferably, the reverse primer is partially identical to the C region sequence of the target nucleic acid. In the immune repertoire, the C region sequences of T cell antigen receptors are substantially identical, while the C region of the BCR is longer and contains multiple constant region fragments (CH1, CH2, CH3, etc.), which differ in different types of antibodies (such as IgG, IgA, IgM, etc.). Therefore, preferably, the first primer pair comprises multiple pairs of first primer pairs with different sequences.

[0014] In one embodiment, the method further includes step (4): performing a second enrichment on the first enriched library molecule with a second primer pair to obtain a second enriched library molecule.

[0015] In one embodiment, the non-complementary extension region of the second primer includes a sequencing adapter sequence, and therefore the second enriched library molecule includes sequencing adapters at both ends.

[0016] In one embodiment, the capture is performed in any of the following ways:

[0017] (i) A space chip is provided, the surface of which is fixed with a capture probe, the capture probe comprising, from 5' to 3': a first universal sequence, a space barcode sequence, and a capture sequence; the space chip is brought into contact with a sample containing an immune repertoire, the capture sequence being complementary to RNA in the immune repertoire and subsequently extended using RNA from the immune repertoire and template-changing oligonucleotides (TSO) as templates to obtain space barcode-labeled cDNA; wherein the template-changing oligonucleotides include a complementary sequence to the second universal sequence; or

[0018] (ii) A space probe is fixed on the surface of the space chip, and the space probe includes, from 5' to 3', a first universal sequence and a space barcode sequence; the space chip, free oligonucleotide, and splint are brought into contact with a sample containing an immune repertoire, the 3' end of the free oligonucleotide is complementary to the RNA in the immune repertoire, and an extension reaction is performed sequentially using the RNA of the immune repertoire and template-changing oligonucleotide (TSO) as templates; the space probe and the free oligonucleotide undergo a splint-dependent ligation reaction to obtain space barcode-labeled cDNA; wherein, the template-changing oligonucleotide includes a complementary sequence of the second universal sequence; the ligation reaction and the extension reaction are performed in any order.

[0019] In one embodiment, the spatial barcode-tagged cDNA is obtained according to method (i).

[0020] Those skilled in the art will understand that the splint sequence includes a 5' complementary region to the free oligonucleotide and a 3' complementary region to the space probe, thereby enabling the 5' end of the free oligonucleotide to be linked to the 3' end of the space probe. In one embodiment, the space probe includes, from 5' to 3', a first universal sequence, a spatial barcode sequence, and a third universal sequence; the free oligonucleotide includes, from 5' to 3', a fourth universal sequence and a capture sequence; the capture sequence is complementary to the RNA and initiates an extension reaction; and the splint includes, from 5' to 3', a fully or partially complementary sequence of the fourth universal sequence and a fully or partially complementary sequence of the third universal sequence.

[0021] Optionally, the 3' end of the spatial barcode sequence further includes a unique molecular identification tag (UMI).

[0022] Preferably, the UMI sequence is a nucleotide sequence consisting of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., 5-100, 5-50, 5-20, e.g., 10) N, each N being independently any one of A, C, G, and T;

[0023] Preferably, the unique molecular identification tag is located between the capture sequence and the spatial barcode sequence;

[0024] Preferably, the forward primer is complementary to the sequence between the capture sequence and the unique molecular recognition tag (fixed sequence 2).

[0025] In one embodiment, the spatially barcoded cDNA includes, from 5' to 3', a first universal sequence, a spatial barcode sequence, a capture sequence, a target nucleic acid C region sequence, a target nucleic acid J region sequence, a target nucleic acid D region sequence, a target nucleic acid V region sequence, and a second universal sequence.

[0026] In one embodiment, the 3' end of the spatial barcode sequence further includes a unique molecular identification tag (UMI).

[0027] In one embodiment, the second universal sequence is a complementary sequence of TSO.

[0028] A second aspect of the present invention provides a method for 5' end sequencing of a spatial transcriptome library of an immune repertoire, the method comprising:

[0029] S1: Construct a spatial transcriptome sequencing library according to the content of the first aspect above;

[0030] S2: Sequencing the spatial transcriptome sequencing library to obtain the 5' end sequence information and spatial information of the immune repertoire.

[0031] The sequencing can be any method known to those skilled in the art, such as next-generation sequencing, rolling circle sequencing, bridge sequencing, etc. Sequencing the 5' end of the spatial transcriptome library of the immune repertoire allows for the reconstruction of the location of immune cells using spatial barcodes, thus grouping sequence information from the same location to the same cell. Furthermore, it reveals the expression differences among each cell, especially the diversity of the V region.

[0032] The advantages and technical effects brought about by the independent claims of the present invention are as follows: Spatiotemporal transcriptomics technology can simultaneously detect the spatial location information and gene expression information of cells in tissues. Currently, no technology can realize immune repertoire sequencing technology based on spatiotemporal transcriptomics. This invention aims to innovatively achieve targeted enrichment and high-throughput sequencing of TCR / BCR sequences based on BGI's independently developed Stereo-seq spatiotemporal transcriptomics, for observing the spatiotemporal map of immune cell gene expression and immune response. This invention can be used to spatially locate the distribution and infiltration status of immune cells in tissues, determine the clonal type of tissue immune cells, and read TCR / BCR receptor gene sequences that can recognize specific antigens, etc., with broad application prospects. Attached Figure Description

[0033] Figure 1 These are diagrams of the original cDNA library molecular structure, the circularized library molecular structure, the library molecular structure after one round of enrichment, and the library molecular structure after two rounds of enrichment according to the present invention.

[0034] Figure 2 It refers to the capture status of TCR and BCR cells. Figure 2 A is a heatmap of gene expression across the entire transcriptome. Figure 2 B and C represent the number of TCR clonal type-annotated cells successfully captured spatiotemporally. Figure 2 D and E represent the number of BCR clones successfully annotated in spatiotemporal capture. Detailed Implementation

[0035] Embodiments of the present invention are described in detail below, examples of which are illustrated in the accompanying drawings. The embodiments described below with reference to the accompanying drawings are exemplary and intended to explain the present invention, and should not be construed as limiting the present invention.

[0036] The immune repertoire (IR) refers to the sum of all rearranged TCR and BCR encoding genes (clones) in the body, including TRA, TRB, TRD, TRG, IGH, IGK, and IGL.

[0037] In the immune repertoire, regions C, J, and D refer to different gene segments involved in the rearrangement of the T cell receptor (TCR) and B cell receptor (BCR) genes, respectively.

[0038] C region (Constant region): This is one of the gene segments of the TCR and BCR, responsible for encoding the constant part of the receptor. This part varies little in different TCRs or BCRs and is mainly responsible for the stability of structure and function.

[0039] J region (Joining region): This is the gene segment used to connect the V region (variable region) and the D region (diversity region) during TCR and BCR gene rearrangement. The J region provides diversity during the rearrangement process.

[0040] The D region (Diversity region) is found only in the TCR β chain and BCR heavy chain, and is a gene segment that provides additional diversity. During rearrangement, the D region binds to the V and J regions, forming highly diverse antigen-binding sites.

[0041] The V region is a variable region located at the front of the TCR and BCR, responsible for encoding the main part of the antigen-binding site. The diversity of the V region mainly comes from the selection and recombination of different V gene fragments.

[0042] Unless otherwise specified, the experimental methods used in the following examples are conventional methods, performed according to the techniques or conditions described in the literature in this field or according to the product instructions. Unless otherwise specified, the materials and reagents used in the following examples are commercially available.

[0043] Unless otherwise specified, the quantitative experiments in the following examples are all repeated three times, and the results are averaged.

[0044] Example 1

[0045] The spatiotemporal transcriptome immune repertoire sequencing method of the present invention successfully achieved TCR-BCR gene-specific spatiotemporal enrichment in frozen lung cancer samples, comprising the following steps:

[0046] 1. cDNA collection: mRNA was captured in situ using the Stereo-seq spatiotemporal chip. cDNA was obtained by reverse transcription, amplification and purification using the Stereo-seq transcriptome reagent kit (201ST114) according to the product instructions. This cDNA was then used as a template for enrichment of the immune repertoire.

[0047] 2. cDNA Circularization: Linear DNA was circularized, and the circularized cDNA was purified to serve as a template for amplification. The cDNA molecule was denatured at high temperature. Splint-Oligosin primers complementary to the target primer adapter and universal primers were designed. After denaturation, the primers were annealed at 42°C, followed by ligation with T4 DNA (TAKARA) ligase. The amount of TCR / BCR DNA product was 500 ng, and the final concentration of the splint-Oligosin primers was 10 μM. After thoroughly mixing the reaction mixture, the primers were denatured at 95°C for 5 min and annealed at 40°C for 10 min. At this point, one end of the splint-Oligosin primer was complementary to the target primer adapter sequence, and the other end was complementary to the universal primer sequence of the same cDNA molecule, forming a circular structure. Then, 0.5 μl of T4 ligase was added, and the mixture was incubated at 37°C for 30 min. At this point, the single-stranded DNA complementary to the splint-Oligosin primers were ligated end-to-end, forming a circular DNA. The circular DNA was then purified using magnetic beads.

[0048] 3. One-round enrichment: Primers specifically binding to the conserved C-region gene in the TCR / BCR were designed using Primer 5 software (Table 1). One-round enrichment was achieved using the C-region TCR / BCR mix primer and adapter 1 to amplify the immune repertoire molecule with spatial location information. In a PCR tube, 54 μl of the PCR amplification mixture (as shown in Table 2) was added to a total of 100 μl for PCR reaction. The PCR reaction steps were: ① 95℃ for 5 minutes, ② 98℃ for 20 seconds, ③ 58℃ for 20 seconds, ④ 72℃ for 3 minutes. Reaction steps ②–④ were repeated for 15 cycles, followed by 72℃ for 5 minutes. The tube was then placed on ice. The concentration of amplified cDNA was detected using Qubit dsDNA Mix: Invitrogen™ Qubit dsDNA HS Buffer 198 μl, Qubit dsDNA HS Reagent 200 × 1 μl, and cDNA product 1 μl. Except for the TCRBCR Primer Mix (10umol) reagent, all other reagents were from the Spacetime Stereo-seq Transcriptome Reagent Kit (201ST114).

[0049] 4. cDNA Purification: Transfer the PCR product from the previous step to a new 1.5ml centrifuge tube, mix with VAHTS™ DNA Clean Beads (VAZYME) equilibrated at room temperature at a volume ratio of 1:0.8, vortex to mix, and incubate at room temperature for 10 minutes. After brief centrifugation, place the EP tube on a magnetic rack and let it stand for 3 minutes until the liquid is clear, then remove the supernatant. Add 1ml of freshly prepared 80% ethanol, let it stand for 30 seconds, discard the supernatant, and repeat the washing with 80% ethanol once, discarding the supernatant. Air dry at room temperature until the surface of the magnetic beads is no longer reflective and cracked. Add 40μl of NF-H2O to reconstitute, vortex to mix, and let it stand at room temperature for 5 minutes. After brief centrifugation, let it stand on a magnetic rack for 3-5 minutes until the liquid is clear, then collect the supernatant into a new 1.5ml centrifuge tube. Take 1μl of cDNA sample and use the Qubit dsDNAHS Kit to detect the concentration, and use the Agilent 2100 High Sensitivity DNA kit to detect the distribution of cDNA fragments. (QC standard: Fragment size is mainly distributed in 1000-1500bp)

[0050] 5. Second-round enrichment: A second round of enrichment was performed using Adapter-F and R primers (same as described in step 3 except for the primers) to obtain immune library molecules with adapter sequences. The specific library structure is as follows:

[0051] 6. Sequencing: The enriched cDNA library was circularized, sequenced, and analyzed. Using BGI's proprietary DNB preparation kit (1000028504), 80 ng of the purified product was added to a new PCR tube, NF-H2O was added to bring the volume to 20 μl, and 20 μl of Make DNB buffer was added. The reaction was carried out in a PCR instrument at 95℃ for 3 minutes, then at 40℃ for 3 minutes. After removing the reaction solution, it was placed on ice, and 40 μl of Make DNB Enzyme Mix I and 4 μl of Make DNB Enzyme Mix II were added. The reaction was carried out in a PCR instrument at 30℃ for 30 minutes. After removing the solution, 20 μl of DNB stop buffer was added and mixed well. This yielded the circularized DNB library. The library was sequenced using an MGISEQ-2000RS sequencer. Offline data is automatically analyzed at https: / / cloud.stomics.tech / # / dashboard Home (stomics.tech) to ultimately obtain heatmap results. Figure 2 ).

[0052] This invention is a spatiotemporal transcriptome immune repertoire sequencing method that enables next-generation sequencing of the TCR / BCR variable regions, thereby achieving spatiotemporal localization and gene sequencing of monoclonal immune cells.

[0053] Table 1 Sequence Information

[0054]

[0055]

[0056] r represents ribonucleotide, and iXNA represents locked nucleic acid.

[0057] Table 2 PCR amplification Mix

[0058] Reagent Name 1x(μl) cDNA Amplification Mix 54 TCR BCR Primer Mix 4 Recover cDNA samples 42 Total 100

[0059] Furthermore, the terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one of that feature. In the description of this invention, "a plurality of" means at least two, such as two, three, etc., unless otherwise explicitly specified.

[0060] In this invention, the terms "one embodiment," "some embodiments," "example," "specific example," or "some examples," etc., refer to a specific feature, structure, material, or characteristic described in connection with that embodiment or example, which is included in at least one embodiment or example of the invention. In this specification, the illustrative expressions of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials, or characteristics described may be combined in any suitable manner in one or more embodiments or examples. Moreover, without contradiction, those skilled in the art can combine and integrate the different embodiments or examples described in this specification, as well as the features of different embodiments or examples.

[0061] Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention. Those skilled in the art can make changes, modifications, substitutions and variations to the above embodiments within the scope of the present invention.

Claims

1. A method for constructing a spatial transcriptome sequencing library based on an immune repertoire, characterized in that... The method includes the following steps: (1) RNA from the immune repertoire was captured using a space chip to obtain spatially barcode-labeled cDNA; The spatially barcoded cDNA includes, from 5' to 3', a first universal sequence, a spatial barcode sequence, a capture sequence, a target nucleic acid C region sequence, a target nucleic acid V region sequence, and a second universal sequence; (2) Connect the 5' end of the first universal sequence to the 3' end of the second universal sequence to circularize the spatial barcode-tagged cDNA; (3) The circularized spatially barcoded cDNA is enriched using the first primer pair to obtain the first enriched library molecule; the first enriched library molecule includes the following from 5' to 3': capture sequence, spatially barcoded sequence, first universal sequence, second universal sequence, target nucleic acid V region sequence and target nucleic acid C region sequence; The first primer pair includes a forward primer and a reverse primer. The forward primer is partially or completely complementary to the capture sequence, the target nucleic acid C region sequence, or a sequence between the two. The reverse primer is partially or completely identical to the capture sequence, the target nucleic acid C region sequence, or a sequence between the two.

2. The method as described in claim 1, characterized in that: The reverse primer is identical to the C region sequence of the target nucleic acid. Preferably, the first primer pair includes at least 1 pair, at least 2 pairs, at least 3 pairs, at least 4 pairs, at least 5 pairs, or at least 6 pairs of first primer pairs; wherein each pair of first primer pairs has a forward primer and / or a reverse primer that is different from the other first primer pairs.

3. The method as described in claim 1 or 2, characterized in that: The method further includes step (4): using a second primer pair to perform a second enrichment on the first enriched library molecule to obtain a second enriched library molecule.

4. The method as described in claim 3, characterized in that: The non-complementary extension region of the second primer pair includes a sequencing adapter sequence, such that the second enriched library molecule includes sequencing adapters at both ends.

5. The method according to any one of claims 1-4, characterized in that... The capture is performed using any of the following methods: (i) A space chip is provided, the surface of which is fixed with a capture probe, the capture probe comprising, from 5' to 3': a first universal sequence, a space barcode sequence, and a capture sequence; the space chip is brought into contact with a sample containing an immune repertoire, the capture sequence being complementary to RNA in the immune repertoire and subsequently extended using RNA from the immune repertoire and template-converting oligonucleotides as templates to obtain space barcode-labeled cDNA; wherein the template-converting oligonucleotides include a complementary sequence to the second universal sequence; or (ii) A space probe is fixed on the surface of the space chip, and the space probe includes, from 5' to 3', a first universal sequence and a space barcode sequence; the space chip, free oligonucleotide, and split are brought into contact with a sample containing an immune repertoire, the 3' end of the free oligonucleotide is complementary to the RNA in the immune repertoire, and an extension reaction is performed sequentially using the RNA of the immune repertoire and the template-converting oligonucleotide as templates; the space probe and the free oligonucleotide undergo a split-dependent ligation reaction to obtain space barcode-labeled cDNA; wherein, the template-converting oligonucleotide includes a complementary sequence of the second universal sequence; the ligation reaction and the extension reaction are performed in any order.

6. The method as described in claim 5, characterized in that: The space probe includes, from 5' to 3', a first universal sequence, a space barcode sequence, and a third universal sequence; the free oligonucleotide includes, from 5' to 3', a fourth universal sequence and a capture sequence; the capture sequence is complementary to the RNA and initiates an extension reaction, and the split includes, from 5' to 3', a fully or partially complementary sequence of the fourth universal sequence and a fully or partially complementary sequence of the third universal sequence.

7. The method according to any one of claims 1-6, characterized in that: The 3' end of the spatial barcode sequence also includes a unique molecular identification tag; Preferably, the unique molecular identification tag is a nucleotide sequence consisting of at least one N, where each N is independently any one of A, C, G, and T; Preferably, the unique molecular identification tag is located between the capture sequence and the spatial barcode sequence; Preferably, the forward primer is sequence-complementary to the capture sequence and the unique molecular recognition tag.

8. The method according to any one of claims 1-7, characterized in that: The spatially barcoded cDNA includes, from 5' to 3', a first universal sequence, a spatial barcode sequence, a capture sequence, a target nucleic acid C region sequence, a target nucleic acid J region sequence, a target nucleic acid D region sequence, a target nucleic acid V region sequence, and a second universal sequence.

9. The method according to any one of claims 1-8, characterized in that: The second universal sequence is the complementary sequence of TS0.

10. A method for 5' end sequencing of a spatial transcriptome library of an immune repertoire, characterized in that... The method includes: S1: Construct a spatial transcriptome sequencing library according to the method of any one of claims 1-9; S2: Sequencing the spatial transcriptome sequencing library to obtain the 5' end sequence information and spatial information of the immune repertoire.